Fitness Profiling Links Topoisomerase II Regulation of Centromeric Integrity to Doxorubicin Resistance in Fission Yeast

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Nguyen, Thi Thuy Trang ^a,b   Lim, Julia Sze Lynn ^a,b   Tang, Richard Ming Yi ^a,b   Zhang, Louxin ^a,c   Chen, Ee Sin ^a,b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; NONHISTONE PROTEIN;

ANTIFUNGAL RESISTANCE; CENTROMERE; CHROMOSOME ABERRATION; CLUSTER ANALYSIS; DRUG EFFECTS; EPISTASIS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; METABOLISM; MUTATION; PHYSIOLOGY; REPRODUCTIVE FITNESS; SCHIZOSACCHAROMYCES;

CENTROMERE; CHROMOSOMAL PROTEINS, NON-HISTONE; CHROMOSOME ABERRATIONS; CLUSTER ANALYSIS; DNA TOPOISOMERASES, TYPE II; DOXORUBICIN; DRUG RESISTANCE, FUNGAL; EPISTASIS, GENETIC; GENE EXPRESSION REGULATION, FUNGAL; GENETIC FITNESS; MUTATION; SCHIZOSACCHAROMYCES; TRANSCRIPTION, GENETIC;

EID: 84925196829     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08400     Document Type: Article

References (58)

1. Carvalho, F. S. et al. Doxorubicin-induced cardiotoxicity: from bioenergetics failure and cell death to cardiomyopathy. Med. Res. Rev. 34, 106-135 (2014).
2. Tacar, O., Sriamornsak, P. & Dass, C. R. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J. Pharm. Pharmacol. 65, 157-170 (2013).
3. Zheng, Z. et al. An ancestral haplotype defines susceptibility to doxorubicin nephropathy in the laboratory mouse. J. Am. Soc. Nephrol. 17, 1796-1800 (2006).
4. Jamieson, D. & Boddy, A. V. Pharmacogenetics of genes across the doxorubicin pathway. Expert Opin. Drug Metab. Toxicol. 7, 1201-1210 (2011).
5. Carvalho, C. et al. Doxorubicin: the good, the bad and the ugly effect. Curr. Med. Chem. 16, 3267-3285 (2009).
6. Pommier, Y., Leo, E., Zhang, H. & Marchand, C. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem. Biol. 17, 421-433 (2010).
7. Pang, B. et al. Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin. Nat. Commun. 4, 1908 (2013).
8. Yang, F., Kemp, C. J. & Henikoff, S. Doxorubicin enhances nucleosome turnover around promoters. Curr. Biol. 23, 782-787 (2013).
9. Im, J. S. et al. ATR checkpoint kinase and CRL1bTRCP collaborate to degrade ASF1a and thus repress genes overlapping with clusters of stalled replication forks. Genes Dev. 28, 875-887 (2014).
10. Tay, Z. et al. Cellular robustness conferred by genetic crosstalk underlies resistance against chemotherapeutic drug doxorubicin in fission yeast. PLoS One 8, e55041 (2013).
11. Tay, Z. et al. P-glycoprotein and vacuolar ATPase synergistically confer anthracycline resistance to fission yeast and human cells. Curr. Med. Chem. 21, 251-260 (2014).
12. Shiozaki, K. & Yanagida, M. A. Functional 125-kDa core polypeptide of fission yeast DNA topoisomerase II. Mol. Cell. Biol. 11, 6093-6102 (1991).
13. Nakazawa, N., Mehrotra, R., Ebe, M. & Yanagida, M. Condensin phosphorylated by the aurora-like kinase Ark1 is continuously required until telophase in a mode distinct from Top2. J. Cell Sci. 124, 1795-1807 (2011).
14. Wang, J. C. Cellular roles of DNA toposiomerases: a molecular perspective. Nat. Rev. Mol. Cell Biol. 3, 430-440 (2002).
15. Wu, C. C. et al. Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide. Science 333, 459-462 (2011).
16. Germe, T.,Miller, K.&Cooper, J. P. Anon-canonical function of topoisomerase II in disentangling dysfunctional telomeres. EMBO J. 28, 2803-2811 (2009).
17. Hogan, C. J. et al. Fission yeast Iec1-Ino80-mediated nucleosome eviction regulates nucleotide and phosphate metabolism. Mol. Cell. Biol. 30, 657-674 (2010).
18. Helmlinger, D. et al. The S. pombe SAGA complex controls the switch from proliferation to sexual differentiation through the opposing roles of its subunits Gcn5 and Spt8. Genes Dev. 22, 3184-3195 (2008).
19. Monahan, B. J. et al. Fission yeast SWI/SNF and RSC complexes show compositional and functional differences from budding yeast. Nat. Struct. Mol. Biol. 15, 873-880 (2008).
20. Khasanov, F. K. et al. A new recombinational DNA repair gene from Schizosaccharomyces pombe with homology to Escherichia coli Rec A. Genetics 152, 1557-1572 (1999).
21. Dixon, S. J. et al. Systematic mapping of genetic interaction networks. Annu. Rev. Genet. 43, 601-625 (2009).
22. Ward Jr, J. H. Hierarchical grouping to optimize an objective function. J. Am. Stat. Assoc. 58, 236-244 (1963).
23. Miki, R., Saiki, R., Ozoe, Y. & Kawamukai, M. Comparison of a coq7 deletion mutant with other respiration-defective mutants in fission yeast. FEBS J. 275, 5309-5324 (2008).
24. Beernink, H. T. et al. Telomere maintenance in fission yeast requires an Est1 ortholog. Curr. Biol. 13, 575-580 (2003).
25. Cullen, J. K. et al. Break-induced loss of heterozygosity in fission yeast: dual roles for homologous recombination in promoting translocations and preventing de novo telomere addition. Mol. Cell Biol. 27, 7745-7757 (2007).
26. Yamashita, A. et al. The roles of fission yeast Ase1 in mitotic cell division, meiotic nuclear oscillation, and cytokinesis checkpoint signaling. Mol. Biol. Cell 16, 1378-1395 (2005).
27. Tokatlidis, K. et al. Translocation arrest of an intramitochondrial sorting signal next to Tim11 at the inner-membrane import site. Nature 384, 585-588 (1996).
28. Caetano, C., Klier, S. & de Bruin, R. A. Phosphorylation of the MBF repressor Yox1 by the DNA replication checkpoint keeps the G1/S cell-cycle transcriptional program active. PLoS One 6, e17211 (2011).
29. Kim, D. U. et al. Analysis of a genome-wide set of gene deletions in the fission yeast Schizosaccharomyces pombe. Nat. Biotechnol. 28, 617-623 (2010).
30. Bandyopadhyay, S. et al. Rewiring of genetic networks in response to DNA damage. Science 330, 1385-1389 (2010).
31. Cavero, S., Limbo, O. & Russell, P. Critical functions of Rpa3/Ssb3 in S-phase DNA damage responses in fission yeast. PLoS Genet. 6, e1001138 (2010).
32. Natsume, T. et al. A DNA polymerase alpha accessory protein, Mcl1, is required for propagation of centromere structures in fission yeast. PLoS One 3, e2221 (2008).
33. Bhattacharjee, S. et al. MHF1-2/CENP-S-X performs distinct roles in centromere metabolism and genetic recombination. Open Biol. 3, 130102 (2013).
34. Oshiro, T., Aiba, H. & Mizuno, T. A defect in a fatty acyl-CoA synthetase gene, lcf11, results in a decrease in viability after entry into the stationary phase in fission yeast. Mol. Gen. Genomics 269, 437-442 (2003).
35. Nicolas, E. et al. Distinct roles of HDAC complexes in promoter silencing, antisense suppression and DNA damage protection. Nat. Struct. Mol. Biol. 14, 372-380 (2007).
36. Chen, E. S., Saitoh, S., Yanagida, M. & Takahashi, K. A cell cycle-regulated GATA factor promotes centromeric localization of CENP-A in fission yeast. Mol. Cell 11, 175-187 (2003).
37. Takahashi, K., Chen, E. S. & Yanagida, M. Requirement of Mis6 centromere connector for localizing a CENP-A-like protein in fission yeast. Science 288, 2215-2219 (2000).
38. Ohkura, H. et al. Cold-sensitive and caffeine-supersensitive mutants of the Schizosaccharomyces pombe dis genes implicated in sister chromatid separation during mitosis. EMBO J. 7, 1465-1473 (1988).
39. Choi, E. S. et al. Identification of noncoding transcripts from within CENP-A chromatin at fission yeast centromeres. J. Biol. Chem. 286, 23600-23607 (2011).
40. Burgess, D. J. et al. Topoisomerase levels determine chemotherapy response in vitro and in vivo. Proc. Natl. Acad. Sci. U S A 105, 9053-9058 (2008).
41. Wu, C. C. et al. On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs. Nucleic Acids Res. 41, 10630-10640 (2013).
42. Uemura, T. &Yanagida, M. Isolation of type I and IIDNAtopoisomerase mutants from fission yeast: single and double mutants show different phenotypes in cell growth and chromatin organization. EMBO J. 3, 1737-1744 (1984).
43. Gómez, R. et al. Cohesin removal precedes topoisomerase IIa-dependent decatenation at centromeres in male mammalian meiosis II. Chromosoma 123, 129-146 (2014).
44. Bachant, J. et al. The SUMO-1 isopeptidase Smt4 is linked to centromeric cohesion through SUMO-1 modification of DNA topoisomerase II. Mol. Cell 9, 1169-1182 (2002).
45. Toyoda, Y. & Yanagida, M. Coordinated requirements of human topo II and cohesion for metaphase centromere alignment under Mad2-dependent spindle checkpoint surveillance. Mol. Biol. Cell 17, 2287-2302 (2006).
46. Díaz-Martínez, L. A., Giménez-Abián, J. F. & Clarke, D. J. Chromosome cohesion-rings, knots, orcs and fellowship. J. Cell Sci. 121, 2107-2114 (2008).
47. Hoque, M. T. & Ishikawa, F. Cohesin defects lead to premature sister chromatid separation, kinetochore dysfunction, and spindle-assembly checkpoint activation. J. Biol. Chem. 277, 42306-42314 (2002).
48. Hiraoka, Y., Toda, T. & Yanagida, M. The NDA3 gene of fission yeast encodes beta-tubulin: a cold-sensitive nda3 mutation reversibly blocks spindle formation and chromosome movement in mitosis. Cell 39, 349-358 (1984).
49. Castillo, A. G. et al. Plasticity of fission yeast CENP-Achromatin driven by relative levels of histone H3 and H4. PLoS Genet. 3, e121 (2007).
50. Kunitoku, N. et al. CENP-A phosphorylation by Aurora-A in prophase is required for enrichment of Aurora-B at inner centromeres and for kinetochore function. Dev. Cell 5, 853-864 (2003).
51. Jayanthan, A. et al. Occurrence and modulation of therapeutic targets of aurora kinase inhibition in pediatric acute leukemias cells. Leuk. Lymphoma 54, 1505-1516 (2013).
52. Romanelli, A. et al. Inhibiting aurora kinases reduces tumor growth and suppresses tumor recurrence after chemotherapy in patient-derived triplenegative breast cancer xenografts. Mol. Cancer Ther. 11, 2693-2703 (2012).
53. Eom, Y. W. et al. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescencelike phenotype. Oncogene 24, 4765-4777 (2005).
54. Moreno, S., Klar, A. & Nurse, P. Molecular genetic analysis of fission yeast Schizosaccharomyces pombe. Methods Enzymol. 194, 795-823 (1991).
55. Franceschini, A. et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41, D808-D815 (2013).
56. Chen, E. S. et al. Cell cycle control of centromeric repeat transcription and heterochromatin assembly. Nature 451, 734-737 (2008).
57. Schneider, C. A., Rasband, W. S.&Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671-675 (2012).
58. Madej, T. et al. MMDB: 3D structures and macromolecular interactions. Nucleic Acids Res. 40, D461-D464 (2012).